Through large-scale profiling of protein changes in response to drug treatments in cancer cell lines, researchers at The University of Texas MD Anderson Cancer Center…
More lockdowns in Europe as virus outbreaks grow
Austria and Greece on Tuesday will become the latest European nations to impose spirit-crushing curbs to combat the coronavirus surge, with a deadly terrorist attack…
Research team creates a computer model that can predict how COVID-19 spreads in cities
A team of researchers has created a computer model that accurately predicted the spread of COVID-19 in 10 major cities this spring by analyzing three…
Researchers identify genetic elements involved in heart development
The advent of genome science has given researchers an unprecedented ability to understand the root causes of a host of conditions. Justin Cotney, assistant professor…
Warfarin use significantly increases risk of knee and hip replacement in people with OA
New research presented at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that use of warfarin, a vitamin K drug widely prescribed to…
Italy daily virus cases top 31,000 in new record
Italy reported a record number of new coronavirus cases Friday, with over 31,000 people testing positive in a 24-hour period. The latest health ministry figures…
‘Nature doesn’t judge you’: How young people in cities feel about the natural world
If you’re under 30, living in a city in the UK, and especially if you’re in an ethnic minority group, you’re likely to be considered…
Study of COVID-19 levels in oncology staff suggests need for more extensive testing
A study of oncology staff carried out immediately after the spring peak of the COVID-19 pandemic in the UK indicates that many had been infected…
Maternal Use of Valproic Acid Linked to ASD, ADHD in Offspring
THURSDAY, Oct. 29, 2020 — Maternal use of valproic acid, but not lamotrigine, is associated with an increased risk for autism spectrum disorder (ASD) and…
FDA Approves Expanded Indication for Merck’s Keytruda (pembrolizumab) in Adult Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (cHL)
KENILWORTH, N.J.–(BUSINESS WIRE) October 15, 2020 — Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and…